25-Jul-2019 | Zion Market Research
Zion Market Research has published a new report titled “Cancer Registry Software Market by Type (Integrated and Standalone), by Database (Public and Commercial), By Delivery (Cloud and On-Premises), By Application (Cancer Reporting, Product Outcome Evaluation, Clinical Studies, Patient Care Management, and Medical Research), and by End-User (Hospitals, Healthcare Providers, Research Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global cancer registry software market was approximately USD 50 million in 2018 and is expected to generate around USD 100 million by 2025, at a CAGR of around 10.32% between 2019 and 2025.
Cancer registry software maintains records of cancer incidences, lists down the causes and current techniques of cancer healthcare that are being performed. It is a repository that contains information on cancer and its various implications. The cancer registry software market globally is growing due to the increasing cancer incidences, improved healthcare facilities, supportive government initiatives, reducing healthcare costs, rising importance of electronic healthcare records, and escalating requirement to use data related to cancer for surveillance. However, data security and issues related to the privacy of data may limit the cancer registry software market globally in the future.
Browse the full “Cancer Registry Software Market by Type (Integrated and Standalone), by Database (Public and Commercial), By Delivery (Cloud and On-Premises), By Application (Cancer Reporting, Product Outcome Evaluation, Clinical Studies, Patient Care Management, and Medical Research), and by End-User (Hospitals, Healthcare Providers, Research Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/cancer-registry-software-market
The cancer registry software market is divided based on type, database, delivery, application, and end-user. Based on type, the market is divided into integrated and standalone software. The standalone software segment is likely to grow notably in the future, as the software is used by many TPAs and government organizations for registering cancer cases and health management. It is also adaptable and interoperable along with being easy to use. Additionally, it stores and processes registry data and has high flexibility and multiple system use. By database, the market includes commercial and public databases. Based on delivery, the market is categorized into the cloud and on-premises. The application segment comprises cancer reporting, product outcome evaluation, clinical studies, patient care management, and medical research. The end-user segment includes hospitals, healthcare providers, research centers, and others. Research centers generally use this software, as they are responsible for new product development and cancer research using existing patient database.
North America is most the significant contributor to the cancer registry software market share globally, mainly due to the increasing number of hospitals, rising cancer incidences, and growing government initiatives and investments in R&D and IT related to cancer. The European cancer registry software market holds a major share globally, due to the software’s ease of operability and efficient resource planning and rising government funding. This makes the software feasible for quick and easy implementation of business level software solutions in the healthcare market. Companies like Elekta provide highly precise treatments for cancer radiation and voxel-based tools. The Asia Pacific region will experience the highest CAGR in the cancer registry software market in the future, owing to the rapidly growing software demand in India and Singapore. There are various companies providing segment shape optimization, smart sequencing, and tools for data optimization while viewing research data on cancer.
Some noticeable players of the global cancer registry software market are McKesson Corporation, Elekta, C/NET Solutions, Electronic Registry Systems, Rocky Mountain Cancer Data Systems, and Onco.
This report segments the global cancer registry software market into:
Global Cancer Registry Software Market: By Type
Global Cancer Registry Software Market: By Database
Global Cancer Registry Software Market: By Application
Global Cancer Registry Software Market: By Delivery
Global Cancer Registry Software Market: By End-User
Global Cancer Registry Software Market: By Region
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651